LOADING
Comparing NVIDIA Corporation (NVDA) and Thermo Fisher Scientific (TMO) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $4.76T | $212.7B |
| P/E Ratio | 30.1 | 30.1 |
| Forward P/E | 23.6 | 22.4 |
| PEG Ratio | 0.57 | 1.83 |
| EPS | $6.54 | $19.14 |
| Revenue Growth (YoY) | 85.2% | 10.5% |
| Profit Margin | 63.0% | 15.0% |
| Return on Equity | 114.3% | 13.5% |
| Dividend Yield | 0.02% | 0.15% |
| Beta | 2.21 | 0.87 |
| 52-Week High | $236.26 | $642.71 |
| 52-Week Low | $163.85 | $434.83 |
| Volume | -- | -- |
NVIDIA Corporation is the larger company by market capitalization. NVIDIA Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Thermo Fisher Scientific offers a higher dividend yield for income investors. NVIDIA Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.